Pura Vida Investments’s CONMED CNMD Stock Holding History

Pura Vida Investments’s Portfolio CNMD Stock Details CNMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-65,000	Closed	-$8.49M	–	231
2021 Q1	$8.49M	Sell	65,000 -48,802	-43%	-$5.87M	0.24%	82
2020 Q4	$12.7M	Sell	113,802 -85,200	-43%	-$8.07M	0.46%	60
2020 Q3	$15.7M	Buy	199,002 +89,102	+81%	+$7.27M	0.81%	25
2020 Q2	$7.91M	Buy	+109,900	New	+$7.65M	0.76%	34
2020 Q1	–	Sell	-46,330	Closed	-$5.18M	–	103
2019 Q4	$5.18M	Sell	46,330 -1,170	-2%	-$125K	0.46%	53
2019 Q3	$4.57M	Sell	47,500 -2,500	-5%	-$235K	0.78%	43
2019 Q2	$4.28M	Buy	50,000 +10,000	+25%	+$822K	0.65%	56
2019 Q1	$3.33M	Buy	+40,000	New	+$2.91M	0.47%	59
2015 Q2	–	Sell	-93,405	Closed	-$4.72M	–	74
2015 Q1	$4.72M	Buy	+93,405	New	+$4.58M	2.43%	15

Other funds holding CNMD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Pura Vida Investments's CNMD Position: Q2 2021 in Review

Pura Vida Investments sold out of CONMED (CNMD) in Q2 2021, closing a stake of 65,000 shares — an estimated $8.49M sold.

Pura Vida Investments first reported a position in CNMD in Q1 2015 and held it in 9 quarters. The position peaked at $15.7M in Q3 2020. 252 funds tracked by Wall St. Rank hold CNMD as of Q2 2021.

Pura Vida Investments reported no remaining CONMED position as of Q2 2021 after selling out during the quarter.
Pura Vida Investments sold 65,000 CONMED shares in Q2 2021, an estimated $8.49M.
Pura Vida Investments first reported a position in CONMED in Q1 2015 and held it in 9 quarters.
Pura Vida Investments's CONMED position peaked at $15.7M in Q3 2020.
252 funds tracked by Wall St. Rank held CONMED as of Q2 2021.

Based on Pura Vida Investments's 13F filing for Q2 2021, filed 16 Aug 2021.